103 related articles for article (PubMed ID: 1975565)
21. Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancer.
Champeme MH; Bieche I; Latil A; Hacene K; Lidereau R
Int J Cancer; 1992 Jan; 50(1):6-9. PubMed ID: 1345822
[TBL] [Abstract][Full Text] [Related]
22. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.
Kawashima K; Nomura S; Hirai H; Fukushi S; Karube T; Takeuchi K; Naruke T; Nishimura S
Int J Cancer; 1992 Feb; 50(4):557-61. PubMed ID: 1347036
[TBL] [Abstract][Full Text] [Related]
23. Human restriction fragment length polymorphisms and cancer risk assessment.
Krontiris TG; DiMartino NA; Colb M; Mitcheson HD; Parkinson DR
J Cell Biochem; 1986; 30(4):319-29. PubMed ID: 3011817
[TBL] [Abstract][Full Text] [Related]
24. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Deo MG
Br J Cancer; 1990 Apr; 61(4):530-3. PubMed ID: 1970484
[TBL] [Abstract][Full Text] [Related]
25. Ethnic-specific allelic variation within the D1Z2 locus.
Tynan KM; Field LL; Hoar DI
Hum Hered; 1990; 40(1):1-14. PubMed ID: 1968882
[TBL] [Abstract][Full Text] [Related]
26. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
27. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
28. Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patients.
Spinola M; Nomoto T; Manenti G; Falvella FS; Brega Massone PP; Conti B; Cataldo I; Valagussa P; Incarbone M; Miyamoto K; Ushijima T; Dragani TA
Int J Cancer; 2001 Sep; 95(5):329-31. PubMed ID: 11494234
[TBL] [Abstract][Full Text] [Related]
29. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
30. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
[TBL] [Abstract][Full Text] [Related]
31. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
32. Elevated frequency of a specific allele of the L-myc gene in male patients with bone and soft-tissue sarcomas.
Kato M; Toguchida J; Honda K; Sasaki MS; Ikenaga M; Sugimoto M; Yamaguchi T; Kotoura Y; Yamamuro T; Ishizaki K
Int J Cancer; 1990 Jan; 45(1):47-9. PubMed ID: 1967596
[TBL] [Abstract][Full Text] [Related]
33. Mapping of the Hox-3.1 and Myc-1.2 genes on chromosome 15 of the mouse by restriction fragment length variations.
Watanabe T; Ohno K; Shimizu A; Sakai Y; Takahashi M; Takahashi N
Biochem Genet; 1990 Jun; 28(5-6):257-66. PubMed ID: 1975491
[TBL] [Abstract][Full Text] [Related]
34. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
35. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
Sugimura H; Caporaso NE; Shaw GL; Modali RV; Gonzalez FJ; Hoover RN; Resau JH; Trump BF; Weston A; Harris CC
Carcinogenesis; 1990 Sep; 11(9):1527-30. PubMed ID: 1976046
[TBL] [Abstract][Full Text] [Related]
36. The utility of a HindIII polymorphism of factor VIII examined by rapid DNA analysis.
Graham JB; Kunkel GR; Fowlkes DM; Lord ST
Br J Haematol; 1990 Sep; 76(1):75-9. PubMed ID: 1977469
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer.
Persson I; Johansson I; Bergling H; Dahl ML; Seidegård J; Rylander R; Rannug A; Högberg J; Sundberg MI
FEBS Lett; 1993 Mar; 319(3):207-11. PubMed ID: 8096192
[TBL] [Abstract][Full Text] [Related]
38. Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene.
Miura O; Sugahara Y; Nakamura Y; Hirosawa S; Aoki N
Biochemistry; 1989 Jun; 28(12):4934-8. PubMed ID: 2475173
[TBL] [Abstract][Full Text] [Related]
39. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
40. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
